BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37275516)

  • 1.
    Zhao HC; Chen CZ; Tian YZ; Song HQ; Wang XX; Li YJ; He JF; Zhao HL
    iScience; 2023 Jun; 26(6):106862. PubMed ID: 37275516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aquaporin-9, Mediated by IGF2, Suppresses Liver Cancer Stem Cell Properties via Augmenting ROS/β-Catenin/FOXO3a Signaling.
    Zheng X; Li C; Yu K; Shi S; Chen H; Qian Y; Mei Z
    Mol Cancer Res; 2020 Jul; 18(7):992-1003. PubMed ID: 32229502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer Effect of Polyphyllin I in Suppressing Stem Cell-Like Properties of Hepatocellular Carcinoma via the AKT/GSK-3
    Liao M; Du H; Wang B; Huang J; Huang D; Tong G
    Oxid Med Cell Longev; 2022; 2022():4031008. PubMed ID: 36317061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma.
    Zhou L; He L; Liu CH; Qiu H; Zheng L; Sample KM; Wu Q; Li J; Xie K; Ampuero J; Li Z; Lv D; Liu M; Romero-Gómez M; Hu Y; Tang H
    J Exp Clin Cancer Res; 2023 Nov; 42(1):311. PubMed ID: 37993901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventing mitochondrial PD-L1 suppressed IFN-γ-induced cancer stemness in hepatocellular carcinoma by sensitizing sorafenib-induced ferroptosis.
    Li T; Huang HY; Qian B; Wang WH; Yuan Q; Zhang HY; He J; Ni KJ; Wang P; Zhao ZY; He JL; Fu SW; Xu L; Lin YC; Lin ZN
    Free Radic Biol Med; 2024 Feb; 212():360-374. PubMed ID: 38171407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
    Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
    J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells.
    Li Y; Chen G; Han Z; Cheng H; Qiao L; Li Y
    Onco Targets Ther; 2020; 13():9721-9730. PubMed ID: 33061451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salinomycin Suppresses Tumorigenicity of Liver Cancer Stem Cells and Wnt/Beta-catenin Signaling.
    Liu Q; Sun J; Luo Q; Ju Y; Song G
    Curr Stem Cell Res Ther; 2021; 16(5):630-637. PubMed ID: 31971116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma.
    Tey SK; Wong SWK; Chan JYT; Mao X; Ng TH; Yeung CLS; Leung Z; Fung HL; Tang AHN; Wong DKH; Mak LY; Yuen MF; Sin CF; Ng IO; Ma SKY; Lee TKW; Cao P; Zhong K; Gao Y; Yun JP; Yam JWP
    J Hepatol; 2022 Apr; 76(4):883-895. PubMed ID: 34922977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells.
    Chen Y; Wen H; Zhou C; Su Q; Lin Y; Xie Y; Huang Y; Qiu Q; Lin J; Huang X; Tan W; Min C; Wang C
    Exp Cell Res; 2019 May; 378(1):41-50. PubMed ID: 30844387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
    Ma YS; Lv ZW; Yu F; Chang ZY; Cong XL; Zhong XM; Lu GX; Zhu J; Fu D
    J Exp Clin Cancer Res; 2018 Oct; 37(1):252. PubMed ID: 30326936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
    Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
    Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma.
    Zhang Q; Tsui YM; Zhang VX; Lu AJ; Lee JM; Lee E; Cheung GC; Li PM; Cheung ET; Chia NH; Lo IL; Chan AC; Cheung TT; Ng IO; Ho DW
    Theranostics; 2024; 14(2):892-910. PubMed ID: 38169544
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluid shear stress induces cell migration via RhoA-YAP1-autophagy pathway in liver cancer stem cells.
    Yan Z; Guo D; Tao R; Yu X; Zhang J; He Y; Zhang J; Li J; Zhang S; Guo W
    Cell Adh Migr; 2022 Dec; 16(1):94-106. PubMed ID: 35880618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
    Han Q; Chen CA; Yang W; Liang D; Lv HW; Lv GS; Zong QN; Wang HY
    Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):251-261. PubMed ID: 33129711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
    Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
    J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
    Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
    Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
    Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
    Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jiedu Recipe, a compound Chinese herbal medicine, inhibits cancer stemness in hepatocellular carcinoma via Wnt/β-catenin pathway under hypoxia.
    Guo BJ; Ruan Y; Wang YJ; Xiao CL; Zhong ZP; Cheng BB; Du J; Li B; Gu W; Yin ZF
    J Integr Med; 2023 Sep; 21(5):474-486. PubMed ID: 37453868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research Progress on Regulating LncRNAs of Hepatocellular Carcinoma Stem Cells.
    Zhang X; Zhu Y
    Onco Targets Ther; 2021; 14():917-927. PubMed ID: 33603396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.